| __timestamp | Pfizer Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 14097000000 | 1244910 |
| Thursday, January 1, 2015 | 14809000000 | 5029636 |
| Friday, January 1, 2016 | 14837000000 | 4846776 |
| Sunday, January 1, 2017 | 14784000000 | 5329003 |
| Monday, January 1, 2018 | 14455000000 | 7121000 |
| Tuesday, January 1, 2019 | 14350000000 | 9128000 |
| Wednesday, January 1, 2020 | 11615000000 | 10731000 |
| Friday, January 1, 2021 | 12703000000 | 10701000 |
| Saturday, January 1, 2022 | 13677000000 | 16121000 |
| Sunday, January 1, 2023 | 14771000000 | 37021000 |
| Monday, January 1, 2024 | 14730000000 |
Igniting the spark of knowledge
In the world of pharmaceuticals, Pfizer Inc. and Viking Therapeutics, Inc. present a fascinating study in contrasts. Over the past decade, Pfizer's Selling, General, and Administrative (SG&A) expenses have consistently hovered around $14 billion annually, reflecting its status as a global pharmaceutical giant. In stark contrast, Viking Therapeutics, a smaller biotech firm, has seen its SG&A expenses grow from a modest $1.2 million in 2014 to nearly $37 million by 2023, marking a staggering increase of over 2,800%.
This divergence highlights the differing scales and strategies of these companies. While Pfizer's spending reflects its established market presence and extensive operations, Viking's rising expenses indicate its aggressive growth and expansion efforts. As Viking continues to scale, its spending patterns may offer insights into the evolving landscape of biotech innovation.
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Selling, General, and Administrative Costs: Pfizer Inc. vs GSK plc
Who Optimizes SG&A Costs Better? Pfizer Inc. or Pharming Group N.V.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and Rhythm Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Pfizer Inc. or Catalyst Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Pfizer Inc. vs Mesoblast Limited
Breaking Down SG&A Expenses: Pfizer Inc. vs Dynavax Technologies Corporation
Insmed Incorporated or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Viking Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Viking Therapeutics, Inc. vs MannKind Corporation Trends and Insights
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Xencor, Inc.